Andria Langenberg, M.D.

Vice President, Clinical Development

Dr. Langenberg joined Medivation in July 2008 with nearly 20 years of domestic and international clinical research and development experience, including Phase 1-3 vaccine and drug development experience at Chiron Corporation, development for serious pediatric conditions at BioMarin Pharmaceutical Inc. and dermatologic product development at Corgentech, Inc. (Anesiva, Inc.) and Neosil, Inc. Prior to joining Medivation, Dr. Langenberg served as the head of clinical development and a member of the executive management team at Neosil, Inc., a dermatology-focused private biopharmaceutical company. Dr. Langenberg is the author of numerous scientific publications in peer-reviewed journals. She graduated from the University of Nebraska Medical Center with highest distinction and Alpha Omega Alpha, and completed internal medicine and dermatology residency training at the University of California, San Francisco. She is board certified in internal medicine and dermatology and is on the faculty at the University of California, San Francisco.

Top